Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 18 studies | 35% ± 12% | |
epithelial cell | 5 studies | 27% ± 6% | |
glutamatergic neuron | 4 studies | 48% ± 18% | |
GABAergic neuron | 3 studies | 36% ± 12% | |
ependymal cell | 3 studies | 37% ± 12% | |
basal cell | 3 studies | 20% ± 4% | |
astrocyte | 3 studies | 24% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 32% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1197.47 | 1445 / 1445 | 100% | 12.40 | 183 / 183 |
prostate | 100% | 1210.93 | 245 / 245 | 100% | 17.66 | 502 / 502 |
breast | 100% | 748.90 | 459 / 459 | 100% | 13.98 | 1117 / 1118 |
intestine | 100% | 845.60 | 966 / 966 | 100% | 8.46 | 526 / 527 |
kidney | 100% | 1049.37 | 89 / 89 | 100% | 15.09 | 899 / 901 |
ovary | 100% | 898.01 | 180 / 180 | 100% | 10.09 | 429 / 430 |
uterus | 100% | 953.54 | 170 / 170 | 99% | 8.61 | 456 / 459 |
lung | 99% | 942.19 | 575 / 578 | 100% | 10.23 | 1153 / 1155 |
pancreas | 100% | 542.70 | 327 / 328 | 99% | 9.34 | 177 / 178 |
stomach | 100% | 563.17 | 358 / 359 | 99% | 8.43 | 284 / 286 |
thymus | 100% | 1301.27 | 653 / 653 | 99% | 14.98 | 599 / 605 |
bladder | 100% | 976.81 | 21 / 21 | 99% | 7.88 | 498 / 504 |
adrenal gland | 100% | 1121.31 | 258 / 258 | 98% | 9.46 | 225 / 230 |
brain | 98% | 609.25 | 2599 / 2642 | 99% | 8.46 | 700 / 705 |
skin | 100% | 900.38 | 1808 / 1809 | 93% | 5.77 | 438 / 472 |
liver | 98% | 385.58 | 222 / 226 | 64% | 2.90 | 260 / 406 |
spleen | 100% | 450.50 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 618.56 | 1330 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 595.64 | 1199 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 7.99 | 44 / 45 |
heart | 91% | 550.08 | 782 / 861 | 0% | 0 | 0 / 0 |
muscle | 80% | 224.41 | 645 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 75% | 3.33 | 60 / 80 |
peripheral blood | 73% | 220.76 | 682 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 66% | 2.62 | 19 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097729 | Cellular component | 9+2 motile cilium |
GO_0001535 | Cellular component | radial spoke head |
GO_0005929 | Cellular component | cilium |
GO_0005515 | Molecular function | protein binding |
Gene name | RSPH3 |
Protein name | Radial spoke head 3 Radial spoke head protein 3 homolog (A-kinase anchor protein RSPH3) (Radial spoke head-like protein 2) |
Synonyms | RSHL2 RSP3 |
Description | FUNCTION: Functions as part of axonemal radial spoke complexes that play an important part in the motility of sperm and cilia (By similarity). Functions as a protein kinase A-anchoring protein that scaffolds the cAMP-dependent protein kinase holoenzyme. May serve as a point of convergence for MAPK and PKA signaling in cilia . . |
Accessions | ENST00000449822.5 Q86UC2 A0A0C4DG29 ENST00000367069.7 A0A0C4DFU3 |